Average Co-Inventor Count = 5.05
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (45 from 2,070 patents)
2. Pfizer Corporation (17 from 4,447 patents)
3. Other (2 from 831,952 patents)
4. Pfizer Products Inc. (1 from 47 patents)
5. Janssen Pharmaceutica (1 from 32 patents)
65 patents:
1. 12378254 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
2. 12338243 - P2X7 modulators
3. 12247027 - P2X7 modulators
4. 12172997 - Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators
5. 11820770 - P2X7 modulators
6. 11759455 - Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators
7. 11667644 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
8. 11618750 - Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators
9. 11530210 - Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators
10. 11225478 - P2X7 modulators
11. 11207298 - Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators
12. RE48841 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
13. 11161846 - Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators
14. 11059828 - Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators
15. 10766880 - Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators